Romania’s market for mergers & acquisitions (M&A) has remained at around EUR 1 billion in 2013, driven by deals in the banking and renewable sector, although big investors have held back and are carefully planning moves for next year, say deal makers.
By Ovidiu Posirca
Healthcare & Pharma
Curato Rontgen sells Scandia Imagistica to Euromedic International
Value of transaction: Not made public
Legal team, buyer: Not made public
Legal team, seller: KPMG (financial)/Wiersholm
Norway’s Curto Rontgen, a leading provider of medical imaging services, sold Scandia Imagistica, a Romanian company active in the same field, to Euromedic International, one of the biggest healthcare investors and operators in Europe.
Alliance Healthcare Deutschland gains full ownership of Farmexpert
Value of transaction: Not made public
Legal team, buyer: Wolf Theiss
Legal team, seller: Not applicable
German Alliance Healthcare Deutschland, the pharmaceuticals wholesaler part of Alliance Boots Group, gained full ownership of Farmexpert, the pharmaceuticals distributor. The German company acquired the remaining 20 percent in the local distributor from Eugen Banciu, Farmexpert founder. Alliance Healthcare Deutschland acquired a 60 percent stake in the Romanian distributor in 2006, further increasing its controlling stake to 80 percent last year.
Diaverum acquires two local dialysis clinics
Value of transaction: Not made public
Legal team, buyer: DLA Piper
Legal team, seller: Not made public
Swedish firm Diaverum, a provider of private dialysis services, made two acquisitions of dialysis clinics on the local market, in a bid to consolidate its position in Romania. Diaverum entered the local market in late 2011 by acquiring nine clinics owned by the private healthcare provider Polisano. The company is currently the third largest player on a market with an estimated value of EUR 150 million, according to media reports. Below are examples of some of my better works with Photoshop , and an explination why each was done.
Aspen Pharma buys GSK brands
Value of transaction: GBP 700 million (global deal value)
Legal team, buyer: Hammond Bogaru & Associates (local counsel)
Legal team, seller: Not made public
Aspen Pharma acquired from GlaxoSmithKline the Arixtra and Fraxiparine/Fraxodi brands and their business worldwide, including in Romania.